[Macrolides antibiotics and chronic pulmonary disease]

Area of Science:

• Pharmacology
• Pulmonology
• Immunology

Background:

• Macrolides are widely used antibiotics with proven efficacy and bioavailability.
• Emerging evidence suggests macrolides possess immunomodulatory properties beneficial for chronic lung diseases.
• These properties may reduce the frequency of exacerbations in patients with chronic respiratory conditions.

Approach:

• This narrative review synthesizes current scientific evidence.
• It examines international clinical recommendations for macrolide therapy.
• The focus is on frequent chronic respiratory disorders.

Key Points:

• Macrolides demonstrate immunomodulatory effects beyond their antimicrobial activity.
• Therapeutic use of macrolides can decrease exacerbation rates in specific chronic lung diseases.
• Evidence supports their role in managing conditions like COPD and bronchiectasis.

Conclusions:

• Immunomodulatory macrolide therapy is a promising strategy for managing chronic respiratory diseases.
• Further research and clinical guidelines are evolving to optimize their use.
• These antibiotics offer a potential benefit in reducing disease burden and improving patient outcomes.